Abbott Laboratories (ABT) Finished Goods (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Finished Goods data on file, last reported at $4.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 5.19% year-over-year to $4.3 billion; the trailing twelve-month figure through Mar 2026 stood at $4.3 billion (up 5.19% YoY), and the FY2025 full-year result was $4.0 billion, up 7.46% from the prior year.
• Finished Goods grew to $4.3 billion in Q1 2026, from $4.0 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $4.3 billion in Q2 2025 to a low of $3.4 billion in Q3 2022.
• A 5-year average of $3.9 billion and a median of $4.0 billion in 2025 frame the typical range for Finished Goods.
• Across the five-year window, Finished Goods rose 23.5% in 2022 and dropped 6.23% in 2024, its largest moves.
• Tracing ABT's Finished Goods over 5 years: stood at $3.8 billion in 2022, then grew by 3.71% to $3.9 billion in 2023, then decreased by 6.23% to $3.7 billion in 2024, then grew by 7.46% to $4.0 billion in 2025, then climbed by 7.49% to $4.3 billion in 2026.
• Business Quant data shows ABT's Finished Goods at $4.3 billion in Q1 2026, $4.0 billion in Q4 2025, and $4.1 billion in Q3 2025.